| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Renalytix plc | Chief Financial Officer | Ordinary Shares | 1,805,236 | $451,309 | $0.25 | 01 Jul 2023 | Direct |
| bluebird bio, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $4.88 | 02 Jun 2025 | Direct |
| Renalytix plc | Chief Financial Officer | Employee Stock Option (right to buy) | 575,160 | 06 Jul 2023 | Direct | ||
| bluebird bio, Inc. | Chief Financial Officer | Stock Options (Right to buy) | 300,000 | 01 Jul 2024 | Direct | ||
| Star Mountain Credit Opportunities Fund, LP | Director | No securities are beneficially owned | 0 | 13 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLUE | bluebird bio, Inc. | 02 Jun 2025 | 3 | $0 | 4 | Chief Financial Officer | 03 Jun 2025, 17:21 |
| BLUE | bluebird bio, Inc. | 30 Sep 2024 | 1 | $0 | 4 | Chief Financial Officer | 02 Oct 2024, 16:06 |
| BLUE | bluebird bio, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Chief Financial Officer | 03 Jul 2024, 16:05 |
| BLUE | bluebird bio, Inc. | 10 Jun 2024 | 0 | $0 | 3 | Chief Financial Officer | 13 Jun 2024, 17:00 |
| RNLX | Renalytix plc | 06 Jul 2023 | 1 | $0 | 4 | Chief Financial Officer | 07 Jul 2023, 16:24 |
| RNLX | Renalytix plc | 01 Jul 2023 | 0 | $0 | 3 | Chief Financial Officer | 03 Jul 2023, 16:24 |
| NONE | Star Mountain Credit Opportunities Fund, LP | 13 May 2021 | 0 | $0 | 3 | Director | 13 May 2021, 14:52 |